共 50 条
Mucosal permeability and mast cells as targets for functional gastrointestinal disorders
被引:30
|作者:
Keita, Asa V.
[1
]
Soderholm, Johan D.
[1
,2
]
机构:
[1] Linkoping Univ, Div Surg Orthoped & Oncol, Dept Clin & Expt Med, Linkoping, Sweden
[2] Cty Council Ostergotland, Dept Surg, Linkoping, Sweden
基金:
瑞典研究理事会;
关键词:
IRRITABLE-BOWEL-SYNDROME;
VASOACTIVE INTESTINAL POLYPEPTIDE;
DILATED INTERCELLULAR SPACES;
EPITHELIAL BARRIER;
ABDOMINAL-PAIN;
IMMUNE ACTIVATION;
REFLUX DISEASE;
COLONIC-MUCOSA;
STRESS;
MICROBIOTA;
D O I:
10.1016/j.coph.2018.08.011
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The intestinal mucosa is constantly exposed to harmful lumina! content, and uptake is closely controlled and regulated by neuro-immune factors. If control is broken, it might lead to ongoing enhanced mucosal permeability, potentially resulting in functional gastrointestinal disorders. The importance of mast cells in the regulation of the mucosal barrier has become obvious, and increased numbers and more activated mast cells have been observed in irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease. To target the disturbed mucosal permeability, directly or via mast cells, is therefore currently of major interest. For example, administration of mast cell stabilizers and probiotics have shown promising effects in patients with functional gastrointestinal disorders.
引用
收藏
页码:66 / 71
页数:6
相关论文